Outsourced Pharma Webinars

  1. Beyond Solid Phase Synthesis 2/12/2026

    Explore how enzymatic methods, real-time analytics, and AI optimization enhance long-sequence TIDES, improving control, speeding timelines, and supporting sustainable production.

     

  2. Flexibility Or Scale? Navigating The Single Use Vs. Stainless Steel Debate 2/12/2026

    Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.

  3. Imagine The Future: An Enhanced Oligonucleotide Synthesis Process 2/9/2026

    Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.

  4. Your AKTA Oligosynt™ System : It's More Than A Machine 2/9/2026

    Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.

  5. Take The Wheel And Drive Your Oligo Synthesis Where You Want 2/9/2026

    Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

  6. Selecting A Prefillable Syringe System With Confidence 2/5/2026

    Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.

  7. Designing Drug Substance Processes For Fill-Finish Compatibility 2/4/2026

    Integrated KBI and Argonaut solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.

  8. DNA-Encoded Library Data: Unlocking Chemomic Insights For Drug Discovery 2/3/2026

    Discover how chemomic analysis unlocks full DEL datasets to reveal early SAR trends, mechanism clues, and risks to help teams make clearer, data‑driven decisions and build stronger hit‑to‑lead foundations.

  9. Drug Discovery Beyond Rule Of Five: ECCS Class 3 And 4 Strategies 2/3/2026

    Gain practical guidance for advancing bRo5 candidates through improved permeability and metabolic stability with insights on ECCS classes 3 and 4, optimized in vitro tools, and design principles.

  10. Viral Clearance Strategies For Monoclonal Antibodies And Proteins 1/30/2026

    Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.